Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, May 27, 2022
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
[ Fri, May 27th 2022
] - WOPRAI
Oren Livnat Maintained (AVDL) at Strong Buy with Decreased Target to $13 on, May 27th, 2022
Oren Livnat of HC Wainwright & Co., Maintained "Avadel Pharmaceuticals plc" (AVDL) at Strong Buy with Decreased Target from $17 to $13 on, May 27th, 2022.
Oren, nor any peers, have made any analyst calls on AVDL in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30